Access Is the Treatment: How Policy Shapes Opioid Use Disorder Care & BuprenorphineIn this Host Rx episode, Dr. O examines a critical reality in addiction medicine: access is not secondary to treatment, access is the treatment.Medications for Opioid Use Disorder (MOUD), including buprenorphine, reduce all-cause mortality by approximately 50%. The evidence is clear. Yet in the United States, who receives these medications often depends on race, income, insurance status, and geography.This episode explores:- Racial disparities in buprenorphine prescribing- Geographic inequities and treatment deserts- Medicaid expansion and insurance barriers- Adolescent access gaps- Telehealth reforms and post-COVID regulatory changes- Structural determinants driving opioid mortalityGrounded in peer-reviewed research and national policy analysis, this episode is designed for clinicians, policymakers, advocates, public health professionals, researchers, trainees in psychiatry and addiction medicine and general public.Because where you live should not determine whether you survive.FEATURED ARTICLES- Lagisetty et al., 2019. Buprenorphine Treatment Divide. JAMA Psychiatry.https://doi.org/10.1001/jamapsychiatry.2019.0876- Krawczyk et al., 2022. Policy Impact on Buprenorphine Access. JAMA Network Open.- Goedel et al., 2021. Structural Determinants of Treatment Access. American Journal of Psychiatry.- Samples et al., 2022. Telehealth and Buprenorphine Access. Health Affairs.- Williams et al., 2023. Treatment Inequities and Policy Reform. Lancet Psychiatry.- Priest et al., 2022. Adolescent Treatment Access. Journal of Adolescent Health.- Clinical guidance: SAMHSA and CDC00:00 Welcome to Transformed Minds01:27 Why Access Matters04:11 Research on Treatment Gaps07:07 Clinician Pipeline and Policy11:16 Frameworks and Care Models12:31 Buprenorphine vs Methadone Systems16:07 Geography Youth and Trauma20:04 Case Study Marcus22:58 How Buprenorphine Works25:50 Access Is the Treatment27:35 Screen Structural Barriers30:55 Final Call to Advocate

Does incarceration actually reduce substance use or does it make it worse?In this episode of The Transformed Mind, Dr. Owusu sits down with forensic and addiction psychiatrist Dr. Jason Barrett to examine the growing body of evidence showing that incarceration is not a deterrent to drug use and may actually increase risk after release, even after controlling for prior substance use.Using longitudinal research on formerly incarcerated Black Americans as a foundation, this conversation moves beyond statistics to explore the lived realities of incarceration, reentry, trauma, and gaps in addiction treatment. Together, they unpack why relapse after release is not a moral failure, but a predictable outcome of disrupted care, untreated trauma, and structural barriers like housing instability, loss of insurance, and lack of access to evidence-based treatment.This episode covers:- Why incarceration predicts drug use independent of prior useCarceral trauma, racialized trauma, and loss of autonomy- Why court-mandated treatment often fails without readiness- The role of clinicians as the “last bridge” for patients- Medication access in jails and prisons (and why continuity of care matters)- How community organizations, peer specialists, and policy reforms can reduce harm- Why addiction should be treated like diabetes, not punished like misconductThis episode is essential listening for clinicians, trainees, policymakers, community advocates, and anyone seeking a more honest, evidence-based conversation about addiction and the justice system.🎧 Listen on Spotify, Apple Podcasts, and wherever you get your podcastsFeatured resources:Rich JD, Wakeman SE, Dickman SL. Return to illicit drug use post-incarceration among formerly incarcerated Black Americans. Drug Alcohol Depend. 2018;187:77–82.Brinkley-Rubinstein L. Incarceration as a social determinant of health. Lancet Public Health. 2018;3:e165–e166.Binswanger IA, et al. Mortality after prison release. N Engl J Med. 2007;356:157–165.National Academies of Sciences. Medications for Opioid Use Disorder Save Lives. 2019.Subscribe for weekly conversations on psychiatry, addiction, and structural health00:00 – Welcome & episode overview02:10 – Why this conversation matters right now04:40 – Intergenerational incarceration, foster care, and homelessness07:30 – Lack of treatment inside jails and prisons10:15 – Why incarceration predicts drug use even after prior use is controlled14:20 – “What does the substance do for you?”18:45 – Trauma, PTSD, ADHD, and untreated psychiatric drivers23:10 – The myth that incarceration stops drug use27:30 – Court-mandated treatment vs readiness for change32:40 – Stages of change and why forced care often fails37:15 – Being the only bridge left for a patient41:50 – Carceral trauma and racialized trauma47:10 – What forensic psychiatry actually is51:30 – How clinicians should assess incarceration history56:20 – Addiction treatment during incarceration: what the evidence shows1:01:10 – Medicaid gaps, reentry, and continuity of care1:07:30 – Community organizations, peer specialists, and rehabilitation1:14:40 – Addiction vs diabetes: dismantling stigma1:21:10 – Case presentation: post-release escalation explained1:28:50 – Evidence-based interventions before release1:35:30 – Final reflections and key takeaways

In the season finale of The Transformed Minds, Dr. O brings the series full circle, reflecting on the season’s core lessons around evidence-based, humane, and equitable care in substance use and psychiatric treatment.

This episode focuses on the heightened risks of the holiday season, a time when emotional stress, trauma activation, social isolation, and structural inequities often collide. Dr. O explores how holiday pressures can exacerbate substance use and psychiatric symptoms, while also highlighting concrete, actionable strategies to promote safety, continuity of care, and recovery.

Drawing on clinical insight and real-world examples, the episode examines:

• The psychology of stress and trauma during the holidays

• Structural vulnerabilities that increase risk for relapse, overdose, and psychiatric crises

• Practical interventions for clinicians, caregivers, policymakers, and communities

From anticipatory care planning and medication continuity to community-level harm reduction strategies such as naloxone distribution and syringe services, this finale underscores a central message of the season: support saves lives.

Join us for a thoughtful, grounded discussion on how to build recovery-friendly environments and reduce harm during one of the most challenging and meaningful times of the year.

Learning Objectives

By the end of this episode, listeners will be able to:

1. Identify evidence-based risk factors for substance use recurrence during the holiday season.

2. Apply practical, anticipatory strategies to reduce relapse and overdose risk.

3. Understand how trauma, social determinants, and system-level gaps shape holiday outcomes.

4. Translate research into actionable steps for clinicians, patients, communities, and policymakers.

5. Reframe holiday substance use risk as predictable and therefore preventable.

Tackling Addiction and Homelessness with Dr. Fabiola Arbelo Cruz

In this episode of the Transformed Minds Podcast, Dr. Owusu speaks with Dr. Fabiola Arbelo Cruz, Addiction Psychiatrist at the Connecticut Mental Health Center and Yale School of Medicine. They explore how mental health, addiction, and homelessness intersect, the barriers unhoused individuals face, and the innovative approaches used by Yale’s Street Psychiatry team.

Dr. Arbelo Cruz discusses treatment engagement, long-acting buprenorphine, peer support, and the policy changes needed to address social determinants of health. A powerful episode for clinicians, policymakers, and advocates seeking meaningful solutions.

Episode Highlights:

• Understanding homelessness and addiction

• Challenges within emergency and street-based care

• Case study insights

• Building trust with unhoused patients

• Effective treatment strategies

• System-level and policy recommendations

Welcome to the Transform Mind Podcast with Dr. O. In today's episode, we delve into the joint clinical practice guidelines for benzodiazepine tapering released in June 2025.

Dr. O breaks down the essential principles, patient-centered approaches, and key recommendations to ensure safe and effective benzodiazepine tapers. Learn why slow and supported tapering, shared decision making, and harm reduction are critical for patient safety. We also discuss special populations, psychosocial interventions, and practical case studies.

Stay tuned to explore this vital topic in psychiatric and addiction care.

00:00 Welcome to Transform Mind Podcast

01:22 Introduction to Today's Topic: Benzo Use Tapering Guidelines

01:51 Overview of the Joint Clinical Practice Guideline

03:37 Key Recommendations and Classifications

05:03 Guiding Principles for Implementation

08:01 Detailed Tapering Strategies

13:52 Special Populations and Considerations

16:50 Case Study: Applying the Guidelines

19:34 Conclusion and Key Takeaways

Featured Resources

What happens when life-saving anxiety medication becomes a system-wide challenge?

In this episode of The Transformed Minds, host Dr. O, unpacks the clinical, systemic, and human dimensions of benzodiazepine use disorder; where relief meets risk.

Drawing from evidence-based literature and the 2025 Joint Clinical Practice Guideline on Benzodiazepine Tapering, we explore how dependence develops, why abrupt discontinuation can be dangerous, and what clinicians, patients, and policymakers can do to build safer, more compassionate systems of care.

You’ll learn:

- How to distinguish dependence from substance use disorder

- The science behind benzodiazepine tapering and withdrawal

- How fragmented healthcare systems complicate deprescribing

- What patient-centered and trauma-informed care looks like in real practice

Listen now, subscribe for future deep dives, and join the conversation at  ⁨@thetransformedmindspod⁩ 

In Part 2 of our conversation with Dr. Chapman, we continue exploring the wholistic approach to Opioid Use Disorder (OUD), diving deep into how economics, genetics, and the state of American healthcare shape treatment and recovery.From the science of addiction to the social systems that sustain it, Dr. Chapman offers valuable insight into building a more compassionate and effective framework for healing.🔗 Subscribe and turn on notifications so you don’t miss it on new episodes every other Tuesday at 11am!

In this episode, we explore how the renowed Dr. Edwin Chapman, a leading physician and researcher, is redefining the treatment of opioid use disorder (OUD) by integrating housing, social determinants of health (SDOH), and genetics into a groundbreaking model of care.

From the streets of Washington, D.C. to advocacy and the latest advances in addiction treatment, Dr. Chapman’s Urban Health Model addresses more than addiction, it treats the whole person. We discuss the role of stable housing and how precision medicine is reshaping addiction care.

Topics Covered:

• Social determinants of health and addiction
• Why housing matters in recovery
• Vulnerability to opioid misuse
• Congressional testimony

Listen now on Spotify, Apple Podcasts, Amazon music and wherever you get your podcasts.

Subscribe for biweekly episodes on health equity, addiction science, and innovation in care.

#OpioidRecovery #DrEdwinChapman #AddictionPsychiatry #AddictionMedicine #SDOH #PublicHealth #UrbanHealthModel #PrecisionMedicine #OUD #HealthEquity #HousingIsHealthcare

In this Host Rx episode, Dr. O explores both sides of kratom.

We break down:

• A 2025 meta-analysis linking long-term kratom use to improved metabolic health.

• A 2021 case series documenting kratom use disorder and its treatment with buprenorphine/naloxone.

Kratom may offer benefits — but it also carries real risks. Join us as we ask what the science actually says and what it means for clinicians, patients, and communities.

Don’t forget to follow for more evidence-informed conversations at the intersection of mental health, addiction, and transformative care.

Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder

Despite proven treatments, access to care remains a major challenge for individuals with opioid use disorder. This episode dives into the barriers—stigma, policy hurdles, and system gaps—and offers strategies for creating a more equitable and effective treatment system.

🎙️ Featuring Dr. Bowe | Yale and WVU-trained, board-certified in Internal Medicine, Psychiatry, and Addiction Psychiatry. Dr. Bowe brings expert insight into how the healthcare system can better respond to the opioid crisis.

🔑 Key Insights:

• Why access to medication-assisted treatment (MAT) matters

• Systemic changes needed for equitable care

• Practical solutions for healthcare providers and policymakers

Tune in to learn how we can break down barriers and save lives.

#OpioidTreatment #AddictionRecovery #PublicHealth #HealthEquity